Whole locus sequencing identifies a prevalent founder deep intronic rpgrip1 pathologic variant in the french leber congenital amaurosis cohort

Abstract

Leber congenital amaurosis (LCA) encompasses the earliest and most severe retinal dys-trophies and can occur as a non‐syndromic or a syndromic disease. Molecular diagnosis in LCA is of particular importance in clinical decision‐making and patient care since it can provide ocular and extraocular prognostics and identify patients eligible to develop gene‐specific therapies. Routine high‐throughput molecular testing in LCA yields 70%–80% of genetic diagnosis. In this study, we aimed to investigate the non‐coding regions of one non‐syndromic LCA gene, RPGRIP1, in a series of six families displaying one single disease allele after a gene‐panel screening of 722 LCA families which identified 26 biallelic RPGRIP1 families. Using trio‐based high‐throughput whole locus sequencing (WLS) for second disease alleles, we identified a founder deep intronic mutation (NM_020366.3:c.1468‐128T>G) in 3/6 families. We employed Sanger sequencing to search for the pathologic variant in unresolved LCA cases (106/722) and identified three additional families (two homozygous and one compound heterozygous with the NM_020366.3:c.930+77A>G deep intronic change). This makes the c.1468‐128T>G the most frequent RPGRIP1 disease allele (8/60, 13%) in our cohort. Studying patient lymphoblasts, we show that the pathologic variant creates a donor splice-site and leads to the insertion of the pseudo‐exon in the mRNA, which we were able to hamper using splice‐switching antisense oligonucleotides (AONs), paving the way to therapies.